352 related articles for article (PubMed ID: 21245043)
21. Molecular parameters of siRNA--cell penetrating peptide nanocomplexes for efficient cellular delivery.
van Asbeck AH; Beyerle A; McNeill H; Bovee-Geurts PH; Lindberg S; Verdurmen WP; Hällbrink M; Langel U; Heidenreich O; Brock R
ACS Nano; 2013 May; 7(5):3797-807. PubMed ID: 23600610
[TBL] [Abstract][Full Text] [Related]
22. Pre-administration of PepFect6-microRNA-146a nanocomplexes inhibits inflammatory responses in keratinocytes and in a mouse model of irritant contact dermatitis.
Urgard E; Lorents A; Klaas M; Padari K; Viil J; Runnel T; Langel K; Kingo K; Tkaczyk E; Langel Ü; Maimets T; Jaks V; Pooga M; Rebane A
J Control Release; 2016 Aug; 235():195-204. PubMed ID: 27269729
[TBL] [Abstract][Full Text] [Related]
23. Solid formulation of cell-penetrating peptide nanocomplexes with siRNA and their stability in simulated gastric conditions.
Ezzat K; Zaghloul EM; El Andaloussi S; Lehto T; El-Sayed R; Magdy T; Smith CI; Langel U
J Control Release; 2012 Aug; 162(1):1-8. PubMed ID: 22698942
[TBL] [Abstract][Full Text] [Related]
24. Cell-Penetrating Peptides Delivering siRNAs: An Overview.
Falato L; Gestin M; Langel Ü
Methods Mol Biol; 2021; 2282():329-352. PubMed ID: 33928583
[TBL] [Abstract][Full Text] [Related]
25. Get out or die trying: Peptide- and protein-based endosomal escape of RNA therapeutics.
Klipp A; Burger M; Leroux JC
Adv Drug Deliv Rev; 2023 Sep; 200():115047. PubMed ID: 37536508
[TBL] [Abstract][Full Text] [Related]
26. Cell penetrating peptides: efficient vectors for delivery of nanoparticles, nanocarriers, therapeutic and diagnostic molecules.
Farkhani SM; Valizadeh A; Karami H; Mohammadi S; Sohrabi N; Badrzadeh F
Peptides; 2014 Jul; 57():78-94. PubMed ID: 24795041
[TBL] [Abstract][Full Text] [Related]
27. Cationic cell-penetrating peptides as vehicles for siRNA delivery.
Beloor J; Zeller S; Choi CS; Lee SK; Kumar P
Ther Deliv; 2015; 6(4):491-507. PubMed ID: 25996046
[TBL] [Abstract][Full Text] [Related]
28. Suppression of Hepatic Inflammation via Systemic siRNA Delivery by Membrane-Disruptive and Endosomolytic Helical Polypeptide Hybrid Nanoparticles.
He H; Zheng N; Song Z; Kim KH; Yao C; Zhang R; Zhang C; Huang Y; Uckun FM; Cheng J; Zhang Y; Yin L
ACS Nano; 2016 Feb; 10(2):1859-70. PubMed ID: 26811880
[TBL] [Abstract][Full Text] [Related]
29. A cell-penetrating helical polymer for siRNA delivery to mammalian cells.
Gabrielson NP; Lu H; Yin L; Kim KH; Cheng J
Mol Ther; 2012 Aug; 20(8):1599-609. PubMed ID: 22643866
[TBL] [Abstract][Full Text] [Related]
30. Cell penetrating peptide-mediated systemic siRNA delivery to the liver.
Hayashi Y; Yamauchi J; Khalil IA; Kajimoto K; Akita H; Harashima H
Int J Pharm; 2011 Oct; 419(1-2):308-13. PubMed ID: 21827843
[TBL] [Abstract][Full Text] [Related]
31. PEGylation rate influences peptide-based nanoparticles mediated siRNA delivery in vitro and in vivo.
Aldrian G; Vaissière A; Konate K; Seisel Q; Vivès E; Fernandez F; Viguier V; Genevois C; Couillaud F; Démèné H; Aggad D; Covinhes A; Barrère-Lemaire S; Deshayes S; Boisguerin P
J Control Release; 2017 Jun; 256():79-91. PubMed ID: 28411182
[TBL] [Abstract][Full Text] [Related]
32. Non-covalent Encapsulation of siRNA with Cell-Penetrating Peptides.
Tuttolomondo M; Ditzel HJ
Methods Mol Biol; 2021; 2282():353-376. PubMed ID: 33928584
[TBL] [Abstract][Full Text] [Related]
33. Multifunctional pH-Sensitive Amino Lipids for siRNA Delivery.
Gujrati M; Vaidya A; Lu ZR
Bioconjug Chem; 2016 Jan; 27(1):19-35. PubMed ID: 26629982
[TBL] [Abstract][Full Text] [Related]
34. Cytoplasm-responsive nanocarriers conjugated with a functional cell-penetrating peptide for systemic siRNA delivery.
Tanaka K; Kanazawa T; Horiuchi S; Ando T; Sugawara K; Takashima Y; Seta Y; Okada H
Int J Pharm; 2013 Oct; 455(1-2):40-7. PubMed ID: 23911914
[TBL] [Abstract][Full Text] [Related]
35. Engineered Histidine-Enriched Facial Lipopeptides for Enhanced Intracellular Delivery of Functional siRNA to Triple Negative Breast Cancer Cells.
Biswas A; Chakraborty K; Dutta C; Mukherjee S; Gayen P; Jan S; Mallick AM; Bhattacharyya D; Sinha Roy R
ACS Appl Mater Interfaces; 2019 Feb; 11(5):4719-4736. PubMed ID: 30628773
[TBL] [Abstract][Full Text] [Related]
36. Cellular siRNA delivery using cell-penetrating peptides modified for endosomal escape.
Endoh T; Ohtsuki T
Adv Drug Deliv Rev; 2009 Jul; 61(9):704-9. PubMed ID: 19383521
[TBL] [Abstract][Full Text] [Related]
37. Delivery of siRNA Complexed with Palmitoylated α-Peptide/β-Peptoid Cell-Penetrating Peptidomimetics: Membrane Interaction and Structural Characterization of a Lipid-Based Nanocarrier System.
Jing X; Foged C; Martin-Bertelsen B; Yaghmur A; Knapp KM; Malmsten M; Franzyk H; Nielsen HM
Mol Pharm; 2016 Jun; 13(6):1739-49. PubMed ID: 26654841
[TBL] [Abstract][Full Text] [Related]
38. Current Challenges in Delivery and Cytosolic Translocation of Therapeutic RNAs.
Johannes L; Lucchino M
Nucleic Acid Ther; 2018 Jun; 28(3):178-193. PubMed ID: 29883296
[TBL] [Abstract][Full Text] [Related]
39. Liquid Crystalline Nanodispersions Functionalized with Cell-Penetrating Peptides for Topical Delivery of Short-Interfering RNAs: A Proposal for Silencing a Pro-Inflammatory Cytokine in Cutaneous Diseases.
Petrilli R; Eloy JO; Praça FS; Del Ciampo JO; Fantini MA; Fonseca MJ; Bentley MV
J Biomed Nanotechnol; 2016 May; 12(5):1063-75. PubMed ID: 27305826
[TBL] [Abstract][Full Text] [Related]
40. Highly efficient delivery of siRNA to a heart transplant model by a novel cell penetrating peptide-dsRNA binding domain.
Li H; Zheng X; Koren V; Vashist YK; Tsui TY
Int J Pharm; 2014 Jul; 469(1):206-13. PubMed ID: 24768403
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
